| Code | 1912D | ||||||||||
| MA number | 29/0210/19-S | ||||||||||
| Product Form: | emp med 7x70 mg (vre.papier/PE/Al/kopol. etylén s metakryl.kys.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Route of admin.: | Cutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 27.06.2019 |
| SPC: |
SPC_Lixim 70 mg_emp med_06/2019_REG.doc
|
| PIL: |
PIL_Lixim 70 mg liečivá náplasť_05.2020.doc
|
| Safety feature | Yes |
| Data update: | 07.05.2024 |
